Flynn James E 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 08:59 am Sale |
2024-09-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 1,781,006 1.900% |
-2,697,586 (-60.23%) |
Filing |
| 2024-02-01 5:28 pm Purchase |
2024-01-23 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 4,478,592 5.250% |
545,455 (+13.87%) |
Filing |
| 2023-02-10 10:01 am Unchanged |
2022-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 3,933,137 6.220% |
0 (Unchanged) |
Filing |
| 2021-03-30 3:40 pm Purchase |
2021-03-30 | 13G | Edgewise Therapeutics, Inc. EWTX |
Flynn James E | 3,933,137 8.270% |
3,933,137 (New Position) |
Filing |